title: Ocular neuromyotonia in a patient with cavernous sinus thrombosis secondary to mucormycosis.
abstract: OBJECTIVE
  To report a case of ocular neuromyotonia occurring after cavernous sinus thrombosis secondary to mucormycosis.
  
  
  METHODS
  Case report. We performed serial comprehensive neuro-ophthalmologic examinations.
  
  
  RESULTS
  Fifteen months after initial total ophthalmoplegia of the right eye and complete right upper eyelid ptosis, isolated ocular neuromyotonia, characterized by episodic upward jerking movements of the right upper eyelid, was noted.
  
  
  CONCLUSIONS
  Ocular neuromyotonia, which usually manifests in patients with a history of intracranial tumors and cranial radiation, may also be secondary to infectious cavernous sinus thrombosis.
authors.affiliation: Department of Ophthalmology, University of Minnesota, USA.
authors.forename: A R
authors.initials: AR
authors.lastname: Harrison
authors.forename: J D
authors.initials: JD
authors.lastname: Wirtschafter
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002426:Cavernous Sinus; D015821:Eye Infections, Fungal / Q000209:etiology; D005141:Eyelid Diseases / Q000382:microbiology*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009091:Mucormycosis / Q000150:complications* / Q000382:microbiology / Q000628:therapy; D009222:Myotonia / Q000382:microbiology*; D009801:Oculomotor Muscles / Q000294:innervation; D009886:Ophthalmoplegia / Q000382:microbiology; D012851:Sinus Thrombosis, Intracranial / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B